Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.
Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study. J Urol. 2007 May; 177(5):1777-81.
View in:
PubMed
subject areas
Adult
Adult
Aged
Aged
Antineoplastic Agents
Antineoplastic Agents
Biomarkers, Tumor
Biomarkers, Tumor
Chemotherapy, Adjuvant
Chemotherapy, Adjuvant
Disease-Free Survival
Disease-Free Survival
Drug Administration Schedule
Drug Administration Schedule
Follow-Up Studies
Follow-Up Studies
Humans
Humans
Male
Male
Middle Aged
Middle Aged
Neoplasm Recurrence, Local
Neoplasm Recurrence, Local
Pilot Projects
Pilot Projects
Prospective Studies
Prospective Studies
Prostatectomy
Prostatectomy
Prostate-Specific Antigen
Prostate-Specific Antigen
Prostatic Neoplasms
Prostatic Neoplasms
Radiation-Sensitizing Agents
Radiation-Sensitizing Agents
Risk Factors
Risk Factors
Survival Rate
Survival Rate
Taxoids
Taxoids
Treatment Outcome
Treatment Outcome
authors with profiles
Michael S Cookson